Britton, AmadeaEmbi, Peter J.Levy, Matthew E.Gaglani, ManjushaDeSilva, Malini B.Dixon, Brian E.Dascomb, KristinPatel, PalakSchrader, Kristin E.Klein, Nicola P.Ong, Toan C.Natarajan, KarthikHartmann, EmilyKharbanda, Anupam B.Irving, Stephanie A.Dickerson, MonicaDunne, Margaret M.Raiyani, ChandniGrannis, Shaun J.Stenehjem, EdwardZerbo, OussenyRao, SuchitraHan, JungmiSloan-Aagard, ChantelGriggs, Eric P.Weber, Zachary A.Murthy, KempapuraFadel, William F.Grisel, NancyMcEvoy, CharleneLewis, NedBarron, Michelle A.Nanez, JuanReese, Sarah E.Mamawala, MufaddalValvi, Nimish R.Arndorfer, JulieGoddard, KristinYang, Duck-HyeFireman, BruceBall, Sarah W.Link-Gelles, RuthNaleway, Allison L.Tenforde, Mark W.2024-06-052024-06-052022-10-21Britton, A., Embi, P. J., Levy, M. E., Gaglani, M., DeSilva, M. B., Dixon, B. E., Dascomb, K., Patel, P., Schrader, K. E., Klein, N. P., Ong, T. C., Natarajan, K., Hartmann, E., Kharbanda, A. B., Irving, S. A., Dickerson, M., Dunne, M. M., Raiyani, C., Grannis, S. J., … Tenforde, M. W. (2022). Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance—VISION Network, 10 States, December 2021—August 2022. Morbidity and Mortality Weekly Report, 71(42), 1335–1342. https://doi.org/10.15585/mmwr.mm7142a4https://hdl.handle.net/1805/41237en-USCC0 1.0 UniversalCOVID-19vaccine effectivenessOmicron variantimmunocompromised adultsArticle